Bogle Investment Management’s Syneron Medical Ltd ELOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-198,453
Closed -$2.09M 431
2017
Q1
$2.09M Buy
198,453
+83,025
+72% +$803K 0.15% 149
2016
Q4
$969K Buy
115,428
+60,639
+111% +$475K 0.07% 256
2016
Q3
$392K Buy
54,789
+8,797
+19% +$61.2K 0.03% 314
2016
Q2
$353K Sell
45,992
-7,403
-14% -$52.8K 0.02% 343
2016
Q1
$390K Sell
53,395
-54,713
-51% -$392K 0.03% 348
2015
Q4
$833K Buy
108,108
+37,231
+53% +$284K 0.06% 284
2015
Q3
$506K Sell
70,877
-37,089
-34% -$356K 0.04% 308
2015
Q2
$1.15M Sell
107,966
-26,419
-20% -$309K 0.09% 246
2015
Q1
$1.66M Buy
+134,385
New +$1.49M 0.11% 212
2014
Q2
Sell
-60,141
Closed -$748K 422
2014
Q1
$748K Sell
60,141
-12,363
-17% -$146K 0.05% 287
2013
Q4
$891K Buy
72,504
+55,564
+328% +$577K 0.08% 236
2013
Q3
$146K Sell
16,940
-101,509
-86% -$876K 0.01% 303
2013
Q2
$1.03M Buy
+118,449
New +$1.06M 0.13% 203

Other funds holding ELOS

Bogle Investment Management's ELOS Position: Q2 2017 in Review

Bogle Investment Management sold out of Syneron Medical Ltd (ELOS) in Q2 2017, closing a stake of 198,453 shares — an estimated $2.09M sold.

Bogle Investment Management first reported a position in ELOS in Q2 2013 and held it in 13 quarters. The position peaked at $2.09M in Q1 2017. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

  • Bogle Investment Management reported no remaining Syneron Medical Ltd position as of Q2 2017 after selling out during the quarter.
  • Bogle Investment Management sold 198,453 Syneron Medical Ltd shares in Q2 2017, an estimated $2.09M.
  • Bogle Investment Management first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 13 quarters.
  • Bogle Investment Management's Syneron Medical Ltd position peaked at $2.09M in Q1 2017.
  • 79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on Bogle Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.